Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Partillion Bioscience
company
About
Functional single-cell analysis platform
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $355.05K
- Industries
- Biotechnology,Health Care,Medical,Service Industry
- Founded date
- Apr 3, 2020
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Partillion Bioscience their technology unlocks the ability to analyze and sort single cells based on secreted proteins.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$1.06M
Partillion Bioscience has raised a total of
$1.06M
in funding over 2 rounds. Their latest funding was raised on
Sep 16, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 16, 2021 | Grant | $355.05K | 1 |
National Institutes of Health
|
— | Detail |
| Jun 16, 2021 | Grant | $255.91K | 1 |
National Science Foundation
|
— | Detail |
| Jun 1, 2021 | Grant | $236.40K | 1 |
National Institutes of Health
|
— | Detail |
| May 1, 2021 | Grant | $219.67K | 1 |
National Institutes of Health
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
4
2
Partillion Bioscience is funded by 2 investors.
National Institutes of Health
and National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
